Topic: patent expirations

Watch close-up

7. Ciprodex

Ciprodex is one of several first-to-file or first-to-market generics Endo aims to launch in the coming years.

The top 10 drugs losing U.S. exclusivity in 2020

Each year, drugmakers lose their monopolies on a slate of big-selling old medicines. While top brands like Lyrica and Herceptin lost exclusivity last year—and more big rollouts are expected for 2021 and beyond—this year's exclusivity losses will cause some significant pain of their own.